Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1983-2-14
pubmed:abstractText
A 10-day course of amoxicillin (250 mg)-potassium clavulanate (125 mg) was administered three times daily to 116 female college students with urinary tract infections. All of the bacterial isolates from these patients were susceptible to amoxicillin-potassium clavulanate in vitro; only 81.0% were susceptible to amoxicillin alone. Evaluations at 1 week after completion of this course showed that clinical and bacteriological cures had been achieved in 96.9% of those who completed therapy. Cures were sustained in 85.6% of the patients examined at 4 weeks after the end of therapy. Therapeutic responses were comparable, irrespective of the results of antibody-coated bacteria tests. All strains of Enterobacteriaceae isolated from the rectal and urogenital sites at 1 week after therapy were susceptible to amoxicillin-potassium clavulanate. The proportion of fecal Escherichia coli resistant to amoxicillin alone increased from 13.3% before therapy to 35.6% at 1 week after therapy. Adverse drug reactions consisted of gastrointestinal symptoms (9.8%) and rashes (4.1%). Sixteen patients (14.2%) developed symptomatic candida vaginitis by 1 week after therapy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-102630, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-1126306, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-13598782, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-13923136, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-14848119, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-310279, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-395156, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4248662, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4276178, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4518352, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4591064, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4920323, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-4943333, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-5325707, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-6102627, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-6967713, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-6968541, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-6972732, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-6990474, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-7012997, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-7027925, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-7192302, http://linkedlifedata.com/resource/pubmed/commentcorrection/7181477-932221
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
672-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Treatment of urinary tract infections with a combination of amoxicillin and clavulanic acid.
pubmed:publicationType
Journal Article